Tatarkiewicz et al. [54] and Usborne et al. [55] reported that animal treatment with GLP-1 receptor agonists—exenatide and dulaglutide—respectively, did not modify plasma level of lipase in different models of DM. Here, GLP1R is linked to diabetes mellitus.